| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |